FIELD: medicine, pharmaceutics.
SUBSTANCE: it is suggested to apply Pro-Gly-Pro tripeptide known as anticoagulant to keep stable norglycemia and stable normoinsulinemia in circulation at no side effects because the above-mentioned tripepetide is being natural human and animal metabolite.
EFFECT: higher efficiency of application.
3 cl, 5 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
APPLICATION OF Pro-Gly-Pro-Leu TETRAPEPTIDE AS AGENT FOR PREVENTION AND TREATMENT OF DIABETES, METHOD FOR PREVENTION AND TREATMENT OF DIABETES AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF DIABETES | 2008 |
|
RU2378005C1 |
METHOD OF TREATING DIABETES IN ANIMALS | 2009 |
|
RU2403910C1 |
ANTIDIABETOGENIC AGENT | 1997 |
|
RU2129435C1 |
USING TETRAPEPTIDE Arg-Pro-Gly-Pro AS AGENT FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, METHOD FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA AND METHOD FOR PREPARING IT | 2013 |
|
RU2538801C2 |
METHOD OF TREATING DIABETES IN MAMMALS AND INTRANASAL PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES IN MAMMALS | 2009 |
|
RU2403909C1 |
DRUG FOR PREVENTION AND TREATMENT OF DIABETES | 2013 |
|
RU2597848C2 |
USING TETRAPEPTIDE Pro-Gly-Pro-Val AS AGENT FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, METHOD FOR PREVENTING AND TREATING LIPID STORAGE DISEASE, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LIPID STORAGE DISEASE AND METHOD FOR PREPARING IT | 2013 |
|
RU2537133C2 |
ADMINISTRATION OF Pro-Gly-Pro PEPTIDE AS INTRANASAL AGENT IN PREVENTION AND TREATMENT OF GASTRIC ULCER IN RATS | 2009 |
|
RU2414923C1 |
METHOD FOR PREVENTING AND TREATING GASTRIC ULCERS IN ANIMALS | 2002 |
|
RU2217158C1 |
METHOD FOR PREVENTION AND TREATMENT OF CARBOHYDRATE AND LIPID METABOLISM DISORDER IN METABOLIC SYNDROME AND ENCEPHALOPATHY, USE OF TETRAPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF SUCH DISORDERS | 2012 |
|
RU2480234C1 |
Authors
Dates
2005-05-27—Published
2004-01-20—Filed